Neurotransmitters and Receptors Flashcards

1
Q

What is the history of glutamate?

A
  • Role as a neurotransmitter first suggest by Hayashi 1954 who injected glutamate into dogs and monkeys resulting in seizures
  • Found to depolarise neurons in cat spinal cord in 1950s
  • J.C watkins did a series of experiments in the 1970s that elucidated the ionotropic subtypes, showed the Mg2+ block in NMDA, and established L-glutamate as main neurotransmitter of CNS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classes of glutamate receptors

A
  1. AMPA
  2. Kainate
  3. NMDA
    ^ all ionotropic
  4. mGluRs
    ^ metabotropic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

EPSP

A

An electrical change (depolarisation) in the membrane of a postsynaptic neuron caused by the binding of an excitatory neurotransmitter from a presynaptic cell to a postsynaptic receptor, makes it more likely for a postsynaptic neuron to generate an action potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

IPSP

A

An electrical change (hyperpolarisation) in the membrane of a postsynaptic neuron caused by the binding of an inhibitory neurotransmitter from a presynaptic cell to a postsynaptic receptor, makes it more difficult for a postsynaptic neuron to generate an action potential.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

AP1 subunit

A

glutaminergic subunit that facilitates calcium permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Current dynamic of NMDA

A

Slow rise and slow decay

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Current dynamic of AMPA

A

Rapid rise and rapid decay

Have varying pore size, depending on # glutamate occupying subunits (more glutamate, bigger pore, bigger EPSP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Current dynamic of Kainate

A

Rapid rise and slow decay

Slow decay partially due to nearby AMPA receptor activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

NMDA antagonist

A

APV/AP5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

AMPA antagonist

A

CQNX, GYKI (AMPA specific)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Kainate antagonist

A

CQNX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Shared features of AMPA and kainate

A

Agonists: glutamate, aspartate, AMPA, quisqualate, kainate
Antagonist: CQNX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Distribution of AMPA

A

AMPA is the most widely expressed glutamate receptor in the brain and is concentrated in:
- CA1
- thalamus
- TE
- cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Kainate distribution

A

Concentrated in
- CA3
- dentate gyrus
- cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Subunit arrangement of glutamate receptors

A

Different subunit arrangements present in a variety of compositions to give rise to receptors with widely different properties

These compositions can change over time, influenced by changes in condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GluA2

A
  • AMPA without GluA2 or the unedited GluA2(Q) are permeable to calcium
  • AMPA with edited GluA2(R) are NOT permeable to calcium (majority)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Catecholamines

A

chemicals that have an amine group with either one (monoamine) or two (indolamine) rings

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Peripheral action of serotonin

A

Serotonin is produced by enterochromaffin cells in the intestinal wall and platelets in the serum
= 90% of serotonin

Acts to regulate vascular tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Central action of serotonin

A

Synthesised across brain, but primarily in the raphe nuclei

Acts as a neurotransmitter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Synthesis of serotonin

A

Tryptophan
- tryptophan hydroxylase
5-hydroxytryptophan
- dopa decarboxylase
Serotonin
- MAO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Marker used to identify serotonergic neurons

A

Tryptophan hydroxylase isoform 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Diversity of serotonin receptors

A

The primordial serotonin receptor is over 750 million years old, and has given rise to the 7 key receptors that provide wide diversity

In addition to the core receptors there are transporter proteins and auto/heteroreceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

5HT1

A

Gai coupled GPCR located throughout the CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

5HT2

A

Gq coupled GPCR that acts to increase phospholipase C, and is located throughout the cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

5HT3

A

Cation channel expressed in cortical interneurons, the hypothalamus and the CTZ

Required the 3A subunit for expression, and can be permeable to calcium depending on subunits expressed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

5HT4

A

Gs coupled GPCR located
in striatum/olfactory system/HPC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

5HT5/6/7

A

Gs coupled GPCRs located
5: whole brain
6: striatum/cortex
7: hypothalamus/cortex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

SERT

A

serotonin transport protein composed of 12 transmembrane domains
- transport is voltage dependent on Cl- and Na+ gradients
- targeted by SSRIs, TCAs, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Serotonin autoreceptor

A

5HTD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

serotonin heteroreceptor

A

alpha-2 heteroreceptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

MAOa

A

Monoamine oxidase A
Degrades NA, 5HT, and DA but has highest affinity for 5HT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

MAOb

A

Monoamine oxidase B
degrades DA and tyramine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Desensitisation of serotonin receptors

A

Desensitisation occurs rapidly through PKC-mediated phosphorylation, which is a calcium dependent process

Reversed via phosphatase action following ligand dissociation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Homeostatic responses to serotonergic activation

A

Desensitisation (rapid)
Internalisation (minutes to hours)
Downregulation (hours to days)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

The monoamine hypothesis of depression

A

Depression is due to a deficiency of noradrenaline and serotonin
- some believe different forms are depression are more related to 5HT deficiency than NE or vice versa
- most antidepressants act on NE/5HT however clinical effects take far longer than pharmacological effects

36
Q

Evidence against monoamine hypothesis of depression

A

Individuals can have high serotonin and depression, or low serotonin and depression

Antidepressants take ~5 weeks to exert clinical effects, yet their pharmacological effects occur rapidly

37
Q

Development of anti-depressants

A

Relatively accidental
- first three were histamine based and created as an aesthetic
- TCAs developed as anti-psychotics
- SSRIs developed due to TCA toxicity

38
Q

Antidepressants

A
  • TCAs (nonselective inhibitors of monoamine uptake)
  • MAOIs (selective MAO inhibitors)
  • SSRIs (inhibit 5HT reuptake)
  • SNRIs (selective noradrenaline uptake inhibitors)
39
Q

Placebo effect of antidepressants

A

A significant portion of anti-depressant effects for mild/moderate depression are due to placebo

Potentially due to effect of participating in a study including
- reduced isolation
- feeling important
- taking initiative

40
Q

MDMA

A

Reverses action of serotonin transporter, causing flood of serotonin at synapse (also affects DA/NA)

Structurally similar to mescaline and amphetamine

Neurotoxicity caused by primary metabolite MDA

41
Q

GABA synthesis

A

conversion of glutamate to GABA vu glutamic acid decarboxylase (GAD65/GAD67)

42
Q

GABA breakdown

A

reuptake into synapse/glial cells via GAT
or
transamination via GABA transaminase (GABA-T)

43
Q

Percentage of GABA in brain synapses

A

30%

44
Q

What is the history of GABA?

A

1800s: It was known as a metabolite of plants and micro-organisms

1900s: isolated as an amino acid in the mouse brain through paper chromatorgraphy

1950: Roberts and Frankel discover GABA in the human brain

45
Q

GABA mechanism of action

A

Binds to result in Cl- influx, which causes an IPSP

46
Q

GABAa structure

A

pentameric structure composed of three different distinct subtypes (a,b,y)

the combination determines the pharmacological characteristics of the receptor

47
Q

Most common composition of GABAa subunits

A

2a 2b 1y

48
Q

Where does GABA bind at GABAa receptors?

A

Between the alpha and beta subunits

49
Q

Where do BZDs bind at GABAa receptors

A

between the alpha and gamma subunits

50
Q

Distribution of GABAa

A

widespread through cortex and hippocampus

51
Q

GABAa antagonists

A

bicuculline (competitive)
picrotoxin (irreversible)

52
Q

GABAa agonists

A

muscimol and isoguvacine

53
Q

BZDs

A

Benzodiazepenes are positive allosteric modulators than bind between the alpha-gamma subunits of GABAa receptors and act to increase Cl- conductance

54
Q

Flumazenil

A

Antagonist at BZD site, thus acts to decrease Cl- conductance, and has an anxiogenic effect

55
Q

Overall effect of high GABA agonists

A

anxiolytic, sedative, hypnotic, muscle relaxant, anti-convulsant, amnesiac, dependency

56
Q

Overall effect of slight GABA agonists

A

anxiolysis

57
Q

Overall effect of slight GABA inverse agonists

A

anxiogenic

58
Q

Overall effect of GABA inverse agonists

A

anxiogenic and pro-convulsant

59
Q

EPM

A

An anxiety assay that uses rodent’s innate fear of open spaces and heights to model anxiolysis

  • time spent in open arms is used as an indication of anxiolysis
  • can only really model acute PTSD
60
Q

Light-dark test

A

An anxiety assay based on the conflict in rodents of innate light aversion and spontaneous exploratory activity

61
Q

Anaesthetic drugs that potentiate GABA response

A

Propofol and Etomidate

62
Q

Mutation that prevents anaesthetic drugs from potentiating GABA responses

A

S270W, a single mutation in the alpha subunit of GABAa

63
Q

Link between GABA and Alzheimers

A

In AD there is abnormal communication between GABAergic neurons and principal neurons

This occurs at the same time as gliosis, toxic metabolite production, and plasticity impairement

64
Q

GABAb structure

A

A GPCR composed of 2 subunits
- B1a/B1b (ligand binding)
AND
- B2

65
Q

Effect of GABAb activation

A

Ligand binding to the B1 subunit results in
- inhibition of adenylate cyclase
- pre-synaptic inhibition through reducing calcium influx
- post-synaptic inhibition by increasing K+ permeability

66
Q

GABAb distribution

A

Present throughout the cortex, in both pre and post synaptic terminals

67
Q

GABAb antagonist

A

saclofen

68
Q

GABAb agonist

A

baclofen

69
Q

GABAc structure

A

Mono-pentameric structures composed of three receptor subunits p1, p2, and p3

70
Q

Location of r1 GABAc

A

retina

71
Q

Location of r2 GABAc

A

CNS

72
Q

GABAc receptors are considered a variant of GABAa despite only 30-38% AA specificity, but do not respond to…

A

bicuculline, baclofen, and BZDs

73
Q

Conditions associated with GABA

A
  • mental health
  • major depression
  • autism
  • huntington’s
  • epilepsy
  • parkinsons
74
Q

What are the three dopaminergic pathways in the brain?

A

Mesolimbic: projections from the VTA to the NA and cortex
Nigrostriatal: projections from the SNpc to the dorsal striatum
Tuberoinfundibular: projections within the hypothalamus to control prolactin secretion

75
Q

D1 receptor family mechanism

A

D1 & D5
- increased cAMP production
- K+ channel inhibition
- Ca2+ channel activation/inhibition
- enhancement of NMDA receptor response

76
Q

D2 receptor family mechanism

A

D2, D3, D4
- decrease cAMP production
- K+ channel activation = decreased post-synaptic excitability
- increased presynaptic inhibition via Ca2+ channels

77
Q

Dopamine receptors in striatum

A

D1, D2, D3, D4, D5 (all of them)

78
Q

Dopamine receptors in the cortex

A

D1, D2, D4

79
Q

Dopamine receptors in the hippocampus

A

D2, D3, D4, D5

80
Q

Dopamine receptors in the nucleus accumbens

A

D3

81
Q

Lifecycle of acetylcholine

A

Choline + Acetyl CoA
via choline acetyltransferase
= Acetylcholine + Coenzyme A

Acetylcholine
via Acetylcholine esterase
= Choline (recycled) + acetate (degraded)

82
Q

nAChR

A

composed of 5 subunits, each with four transmembrane domains and act to facilitate the passage of Na+, K+, and on occasion Ca2+.

83
Q

Homomeric nAChR

A

The homomeric a7 receptor is critically implicated in AD.

These receptor have low affinity for nicotine, can be blocked by a-bungarotoxin, are permeable to Ca2+, and undergo rapid desensitisation.

84
Q

Heteromeric nAChR

A

Heteromeric a4b2 receptors have high affinity for nicotine, are not blocked by a-bungarotoxin, and are moderately permeable to Ca2+.

85
Q

mAChR

A

muscarinic acetylcholine receptors are GPCRs and can be classified into 5 subtypes (M1-5) based on agonist/antagonist selectivity

86
Q

What are 3 main ACh pathways in the brain?

A
  1. Septohippocampal pathway: modulates hippocampal neurons and the formation of new memories
  2. Striatal interneurons: modulates the reinforcing properties of dopamine, and contributes to selection of behaviours
  3. Nucleus basalis: radiate throughout the cortex, and are implicated in AD